Dr. Chhatwal is an Associate Professor of Neurology at Harvard Medical School, and a clinician-scientist based at Massachusetts General Hospital (MGH) and Brigham and Women’s Hospitals (BWH). He cares for patients with neurodegenerative diseases in the Memory Disorders Unit at MGH, with a particular focus on early-onset and genetically-driven Alzheimer’s disease. He has a diverse scientific and educational background that spans molecular, cellular, and systems neuroscience and his research program includes projects using neuroimaging, electrophysiology, biochemistry, molecular biology, genetics, and machine learning.  Supported by the NIH and the Doris Duke Charitable Foundation, Dr. Chhatwal leads research on genetic, vascular, sleep-related, and inflammatory influences on cognitive decline and the accumulation of Alzheimer’s disease pathology. He directs the Translational Neuroscience in Neurodegenerative Diseases (Transcend) Laboratory, part of the Ann Romney Center for Neurologic Disease at BWH.  The Transcend laboratory brings together neuroimaging, clinical, biochemical, and data science experts on Alzheimer’s disease with the goal of developing new biomarkers that elucidate disease mechanisms, identify key drug targets for early intervention, and accelerate the testing of novel therapies.